What we're reading, August 22, 2016: freestanding emergency clinics come under increased scrutiny; hospitals are being more open about medical mistakes; and regulations to blame for rising generic drug prices.
Freestanding emergency centers offer another choice for patients, but the proliferation of these centers is impacting healthcare. According to AP, these centers are taking root in suburbs and affluent neighborhoods, causing challenges for medical clinics and hospitals as the centers siphon away physicians to the detriment of patients in need who live in rural areas. These freestanding emergency rooms have increased from 222 in 2009 to 260 in 2015 and tend to locate in ZIP codes where there are more privately insured patients with higher incomes.
Instead of the usual “deny-and-defend” approach, hospitals are beginning to be more open when there is a medical mistake. Hospitals are beginning to implement approaches for physicians to openly and honestly discuss adverse events with patients and family members, reported Kaiser Health News. Creating such an open environment can reduce serious safety events as physicians learn from past mistakes, but hospitals might have to pay for remedies if the patient believes the hospital was at fault.
Recent regulations imposed on generic drug firms are partly to blame for rising drug prices, Scott Gottlieb, MD, resident fellow at the American Enterprise Institute and former FDA deputy commissioner wrote in a piece for The Wall Street Journal. In addition, Gottlieb pointed to the long review process and regulations that make it economically difficult for more than one generic firm to enter the market.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More